|
시장보고서
상품코드
2078176
충혈 완화제 시장 : 제품 유형별, 충혈 완화제 유형별, 작용기전별, 용도별, 유통 채널별, 지역별Decongestant Market, By Product Type, By Type of Decongestant (Oral Decongestants, Nasal Decongestants ), By Mode of Action, By Application, By Distribution Channel, By Geography |
||||||
충혈 완화제 시장은 2026년에 191억 달러, 2033년까지 302억 6,000만 달러에 이를 것으로 예상되고 있습니다. 또한, 2026-2033년 CAGR 6.8%를 기록할 전망입니다.
| 분석 범위 | 분석 상세 | ||
|---|---|---|---|
| 기준연도 | 2025년 | 시장 규모(2026년) | 191억 달러 |
| 실적 데이터 | 2020-2024년 | 예측 기간 | 2026-2033년 |
| 예측 기간(2026-2033년) CAGR | 6.80% | 예측 금액(2033년) | 302억 6,000만 달러 |
충혈 완화제는 비강 내 혈관을 수축시켜 코막힘을 완화하는 약제입니다. 이 약들은 코 점막의 혈관을 수축시켜 부비동에서 분비물이 배출되도록 돕고, 부기를 완화합니다. 일반적인 충혈 완화제에는 슈도에페드린이나 페닐에프린 등이 있습니다. 이 약들은 신속하고 일시적인 증상 완화를 가져다주며, 감기, 부비동염, 꽃가루 알레르기, 알레르기 등의 증상 치료에 사용됩니다. 다만, 약효가 사라진 후 반동성 코막힘이 발생할 가능성이 있으므로 장기간 사용은 권장되지 않습니다. 장기적인 증상 완화를 위한 대안으로는 생리식염수를 이용한 코 세척, 스테로이드 비강 스프레이, 항히스타민제 등이 있습니다. 특히, 비강 충혈 완화제 스프레이를 과도하게 사용하거나 장기간 사용하면 반동성 비폐색이 발생할 가능성이 있으며, 약물 사용을 중단한 후 비강 충혈이 더욱 악화될 우려가 있습니다.
시장 역학:
세계 충혈 완화제 시장은 주로 전 세계 알레르기 유병률 상승의 영향을 받아 꾸준한 속도로 성장하고 있습니다. 주요 시장 성장 요인으로는 환경 조건의 변화와 도시 지역의 대기 오염으로 인한 계절성 알레르기 질환의 급격한 증가를 들 수 있습니다. 또한, 비강 스프레이나 캡슐과 같은 편리한 투여 방법을 통해 코막힘 증상을 완화하는 효과가 있다는 점에 대한 환자들의 인식이 높아지고 있는 것도 제품의 보급을 뒷받침하고 있습니다. 예를 들어, 대기업들은 더 폭넓은 환자층을 대상으로 하기 위해 제네릭 의약품을 출시하고 있습니다. 한편, 몇 가지 제네릭 충혈 완화제가 일반의약품으로 시중에서 구할 수 있다는 점은 접근성과 합리적인 가격을 보장하며, 시장 수익 확대에 기여하고 있습니다. 그러나 3일을 초과하는 정기적인 복용에 대한 엄격한 규제와 장기 사용에 따른 부작용이 시장 성장을 저해할 것으로 예측됩니다. 또한, 코르티코스테로이드나 면역요법과 같은 대체 치료법에 대한 선호도 역시 2028년까지 업계의 수익성을 어느 정도 제한할 가능성이 있습니다. 그렇긴 하지만, 부작용이 적은 신약 제제의 개발을 목표로 한 지속적인 연구개발 활동은 예측 기간 동안 주요 기업들에게 수익성이 높은 기회를 창출할 것으로 예측됩니다.
본 보고서의 주요 특징
- 본 보고서는 각 부문의 잠재적 수익 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한, 시장 성장 촉진요인 및 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업들이 채택하는 경쟁 전략 등에 관한 중요한 고찰도 제공합니다.
- 세계 충혈 완화제 시장의 주요 기업 프로파일을 각종 지표(기업 개요, 제품 포트폴리오, 주요 동향, 재무 실적, 전략 등)를 바탕으로 수록했습니다.
- 본 보고서의 인사이트를 바탕으로, 마케팅 담당자와 기업 경영진은 향후 제품 출시, 기술 업데이트, 시장 확대 및 마케팅 전략에 관해 충분한 정보를 바탕으로 의사결정을 내릴 수 있습니다.
- '세계 충혈 완화제 시장' 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진출기업, 재무 분석가 등 이 업계의 다양한 이해관계자들을 대상으로 합니다.
- 이해관계자들은 전 세계 충혈 완화제 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 보다 수월하게 할 수 있습니다.
목차
제1장 분석 목적과 전제조건
제2장 시장 전망
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 충혈 완화제 시장 : 제품 유형별(2021-2033년)
제5장 세계의 충혈 완화제 시장 : 충혈 완화제 유형별(2021-2033년)
제6장 세계의 충혈 완화제 시장 : 작용기전별(2021-2033년)
제7장 세계의 충혈 완화제 시장 : 용도별(2021-2033년)
제8장 세계의 충혈 완화제 시장 : 유통 채널별(2021-2033년)
제9장 세계의 충혈 완화제 시장 : 지역별(2021-2033년)
제10장 경쟁 구도
제11장 섹션
LSH 26.07.13Decongestant Market is estimated to be valued at USD 19.10 Bn in 2026 and is expected to reach USD 30.26 Bn by 2033, growing at a compound annual growth rate (CAGR) of 6.8% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 19.10 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 6.80% | 2033 Value Projection: | USD 30.26 Bn |
Decongestants are medications that help relieve nasal congestion by shrinking blood vessels in the nasal passages. They work by constricting the blood vessels in the nasal mucosa, which helps promote the drainage of sinus cavities and reduce swelling. Common decongestants include pseudoephedrine and phenylephrine. They provide rapid, temporary relief and are used to treat conditions like the common cold, sinusitis, hay fever, and allergies. However, prolonged use is not recommended, as rebound congestion may occur once the medication wears off. Alternative options for long-term relief include nasal saline rinses, steroid nasal sprays, and antihistamines. Overuse or prolonged use of nasal decongestant sprays, in particular, can lead to rebound congestion, where the nasal passages become more congested after the medication is discontinued.
Market Dynamics:
The global decongestant market is growing at a steady pace mainly influenced by rising prevalence of allergies worldwide. Some of the key market drivers include rapidly growing rate of seasonal allergy disorders fueled by changing environmental conditions and polluted urban atmospheres. Additionally, increasing patient awareness about effective symptomatic relief of nasal congestion through convenient delivery methods like nasal sprays and capsules is propelling the product adoption. For instance, major companies are launching generic copy products to cater wider patient segments. On the other hand, over-the-counter availability of several generic decongestants ensures easy accessibility and affordability augmenting market revenues. However, stringent regulations pertaining to regular consumption beyond 3 days along with adverse side effects associated with long term use are expected to hamper the market growth. Moreover, preference towards alternative treatment options like corticosteroids and immunotherapy may also limit the industry profitability to some extent through 2028. Nevertheless, ongoing R&D activities aimed at development of novel formulations with fewer side effects will likely create lucrative opportunities for key players over the forecast period. Key features of the study:
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global decongestant market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Johnson & Johnson, Pfizer Inc., GlaxoSmithKline plc, Novartis AG, Sanofi S.A., Bayer AG, Reckitt Benckiser Group plc, Prestige Consumer Healthcare Inc., Procter & Gamble Co., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd, Perrigo Company plc, Church & Dwight Co., Inc., Mylan N.V. Marinomed Biotech AG, Dr. Reddy's Laboratories Ltd
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global decongestant market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global decongestant market
Detailed Segmentation:
- By Product Type (Revenue, USD Bn, 2021 - 2033)
- Tablets
- Capsules
- Nasal Sprays
- Others
- By Type of Decongestant (Revenue, USD Bn, 2021 - 2033)
- Oral Decongestants:
- Pseudoephedrine
- Phenylephrine
- Others
- Nasal Decongestants:
- Oxymetazoline
- Xylometazoline
- Phenylephrine
- Naphazoline
- Others
- By (Revenue, USD Bn, 2021 - 2033) Mode of Action:
- Alpha-Adrenergic Agonists
- Vasoconstrictors
- Others
- By (Revenue, USD Bn, 2021 - 2033) Application:
- Seasonal Allergic Rhinitis
- Perennial Allergic Rhinitis
- Sinusitis
- Nasal Congestion
- Cold and Flu
- Others
- By (Revenue, USD Bn, 2021 - 2033) Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Hyper Market/Super Market
- Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Company Profile:
- Johnson & Johnson
- Pfizer Inc.
- GlaxoSmithKline plc
- Novartis AG
- Sanofi S.A.
- Bayer AG
- Reckitt Benckiser Group plc
- Prestige Consumer Healthcare Inc.
- Procter & Gamble Co.
- Sun Pharmaceutical Industries Ltd.
- Teva Pharmaceutical Industries Ltd.
- Perrigo Company plc
- Church & Dwight Co., Inc.
- Mylan N.V.
- Marinomed Biotech AG
- Reddy's Laboratories Ltd
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet , By Product Type
- Market Snippet , By Type of Decongestant
- Market Snippet , By Mode of Action
- Market Snippet , By Application
- Market Snippet , By Distribution Channel
- Market Snippet , By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Prevalence of Respiratory Conditions
- Side Effects of Decongestants
- Adoption of combination drug formulations
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product launch/Approvals
- PEST Analysis
- Pipeline Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
4. Global Decongestant Market, By Product Type, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Tablets
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Capsules
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Nasal Sprays
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
5. Global Decongestant Market, By Type of Decongestant, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Oral Decongestants
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Pseudoephedrine
- Phenylephrine
- Others
- Nasal Decongestants
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Oxymetazoline
- Xylometazoline
- Phenylephrine
- Naphazoline
- Others
6. Global Decongestant Market, By Mode of Action, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Alpha-Adrenergic Agonists
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Vasoconstrictors
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
7. Global Decongestant Market, By Application, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Seasonal Allergic Rhinitis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Perennial Allergic Rhinitis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Sinusitis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Nasal Congestion
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Cold and Flu
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
8. Global Decongestant Market, By Distribution Channel, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Hyper Market/Super Market
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
9. Global Decongestant Market, By Region, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, By Country, 2023and 2033 (%)
- Y-o-Y Growth Analysis, For Country 2022-2033
- Country Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Type of Decongestant, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Mode of Action, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Countries, 2021 - 2033, (US$ Bn)
- U.S.
- Canada
- Lain America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Type of Decongestant, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Mode of Action, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Countries, 2021 - 2033, (US$ Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Type of Decongestant, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Mode of Action, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Countries, 2021 - 2033, (US$ Bn)
- U.K.
- Germany
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Type of Decongestant, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Mode of Action, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Countries, 2021 - 2033, (US$ Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Type of Decongestant, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Mode of Action, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Countries, 2021 - 2033, (US$ Bn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Type of Decongestant, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Mode of Action, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Countries, 2021 - 2033, (US$ Bn)
- North Africa
- Central Africa
- South Africa
10. Competitive Landscape
- Johnson & Johnson
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Pfizer Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- GlaxoSmithKline plc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Novartis AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Sanofi S.A.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Bayer AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Reckitt Benckiser Group plc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Prestige Consumer Healthcare Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Procter & Gamble Co.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Sun Pharmaceutical Industries Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Teva Pharmaceutical Industries Ltd..
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Perrigo Company plc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Church & Dwight Co., Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Church & Dwight Co., Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Mylan N.V.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Marinomed Biotech AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Reddy's Laboratories Ltd
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Analyst Views
11. Section
- Research Methodology
- About us
